Cristian Hernández-Rocha

Cristian Hernández-Rocha

Auto-generated profile, based on publicly available information

Cristian Hernández-Rocha

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital , Toronto

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Annals of Hepatology
Verified
Journal Article
Open access
OPOme Z. Pérez-Gutiérrez
Ome Z. Pérez-Gutiérrez
CHCristian Hernández-Rocha
Cristian Hernández-Rocha
RCRoberto A. Candia-Balboa
Roberto A. Candia-Balboa
MAMarco A. Arrese
Marco A. Arrese
CBCarlos Benítez
Carlos Benítez
NCNorberto Chavez-Tapia
Norberto Chavez-Tapia
Background. The incidence of liver cirrhosis is significantly high in Latin population. The high prevalence of nonalcoholic fatty liver disease NAFLD is likely partially responsible for these figures. Liver biopsy is not a practical diagnostic option in this scenario. The validation of noninvasive markers of fibrosis is important in populations with a high prevalence of NAFLD. Aim. To compare the diagnostic value of noninvasive assessment systems to detect fibrosis in a cohort of Latin patients with biopsy-proven NAFLD. Material and methods. Patients with biopsy-proven NAFLD were included. Noninvasive evaluations included calculations of NAFLD fibrosis, FIB-4, BARD scores, APRI, and AST/ALT ratio. The sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver-operating characteristic curve (AUROC) were calculated. Results. A total of 228 patients (mean age, 48.6 ± 12.7 years) were included. Fifty-one percent were women; 48% were overweight and 23% were obese. The severity of fibrosis was classified as G0, 56.6%; G1, 25%; G2, 6.6%; G3, 7%; and G4, 4.8%. The AUROC values for advanced fibrosis were 0.72 for the NAFLD fibrosis score, 0.74 for FIB-4 score, 0.67 for AST/ALT ratio, 0.66 for APRI score, and 0.65 for BARD score. In 54% of patients with undetermined FIB-4 score and in 60% of patients with undetermined NAFLD fibrosis score, fibrosis was observed in the liver biopsy. Conclusions. The NAFLD fibrosis, FIB-4, and APRI scores can be used for the noninvasive diagnosis of fibrosis. However, 25% of patients evaluated by these methods have an indeterminate degree of fibrosis.

9 July 2024 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
HLHaim Leibovitzh
Haim Leibovitzh
SNShadi Nayeri
Shadi Nayeri
KBKrzysztof Borowski
Krzysztof Borowski
CHCristian Hernandez-Rocha
Cristian Hernandez-Rocha
SLSun-Ho Lee
Sun-Ho Lee
MSMark S Silverberg
Mark S Silverberg
Primary sclerosing cholangitis associated with inflammatory bowel disease (IBD-PSC) carries significant morbidity compared to IBD without PSC. Alterations in microbial composition and bile acid (BA) profiles have been shown to modulate chronic inflammation in IBD, but data in IBD-PSC is scarce. We aimed to assess the differences in gut microbiome composition as well as in the BA profile and BA-related microbial functions between IBD-PSC and IBD-only. 54 IBD-PSC and 62 IBD-only subjects were enrolled from 2012 to 2021. Baseline samples were collected for fecal DNA shotgun metagenomic sequencing, fecal and serum BA quantitation using mass spectrometry and fecal calprotectin. Liver fibrosis measured by transient elastography (TE) was assessed in the IBD-PSC group. Data was analyzed using general linear regression models and Spearman rank correlation tests. Patients with IBD-PSC had reduced microbial gene richness (p=0.004) and significant compositional shifts (PERMANOVA: R2=0.01, p=0.03) compared to IBD-only. IBD-PSC was associated with altered microbial composition and function, including decreased abundance of Blautia obeum, increased abundance of Veillonella atypica, Veillonella dispar and Clostridium scindens (q<0.05 for all), and increased abundance of microbial genes involved in secondary BA metabolism. Decreased serum sulfated and increased serum conjugated secondary BA were associated with IBD-PSC and increased liver fibrosis. We identified differences in microbial species, functional capacity and serum BA profiles in IBD-PSC compared with IBD-only. Our findings provide insight into the pathophysiology of IBD associated with PSC and suggest possible targets for modulating the risk and course of IBD in subjects with PSC.

2 June 2021 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
CHCristian Hernández-Rocha
Cristian Hernández-Rocha
KBKrzysztof Borowski
Krzysztof Borowski
WTWilliams Turpin
Williams Turpin
MFMelissa Filice
Melissa Filice
SNShadi Nayeri
Shadi Nayeri
MSMark S Silverberg
Mark S Silverberg
Microbial-derived bile acids can modulate host gene expression, and their faecal abundance is decreased in active inflammatory bowel disease [IBD]. We analysed the impact of endoscopic inflammation on microbial genes involved in bile acid biotransformation, and their interaction with host transcriptome in the intestinal mucosa of IBD patients. Endoscopic mucosal biopsies were collected from non-inflamed and inflamed terminal ileum, ascending and sigmoid colon of IBD patients. Prediction of imputed metagenome functional content from 16S rRNA profile and real-time quantitative polymerase chain reaction [qPCR] were utsed to assess microbial bile acid biotransformation gene abundance, and RNA-seq was used for host transcriptome analysis. Linear regression and partial Spearman correlation accounting for age, sex, and IBD type were used to assess the association between microbial genes, inflammation, and host transcriptomics in each biopsy location. A Bayesian network [BN] analysis was fitted to infer the direction of interactions between IBD traits and microbial and host genes. The inferred microbial gene pathway involved in secondary bile acid biosynthesis [ko00121 pathway] was depleted in inflamed terminal ileum of IBD patients compared with non-inflamed tissue. In non-inflamed sigmoid colon, the relative abundance of bile acid-inducible [baiCD] microbial genes was positively correlated with the host Angiopoietin-like 4 [Angptl4] gene expression. The BN analysis suggests that the microbial baiCD gene abundance could affect Angptl4 expression, and this interaction appears to be lost in the presence of inflammation. Endoscopic inflammation affects the abundance of crucial microbial bile acid-metabolising genes and their interaction with Angptl4 in intestinal mucosa of IBD patients.

1 August 2012 in Emerging Infectious Diseases
Verified
Journal Article
Open access
CHCristian Hernández-Rocha
Cristian Hernández-Rocha
Jonathan BarraJonathan Barra
Jonathan Barra
MPMarjorie Pizarro-Guajardo
Marjorie Pizarro-Guajardo
PIPatricio Ibáñez
Patricio Ibáñez
SBSusan Bueno
Susan Bueno
Daniel ParedesDaniel Paredes
Daniel Paredes
This is the publisher’s final pdf. The published article is copyrighted by the Centers for Disease Control and Prevention and can be found at: http://wwwnc.cdc.gov/eid/

1 April 2013 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
CHCristian Hernández-Rocha
Cristian Hernández-Rocha
Jonathan BarraJonathan Barra
Jonathan Barra
MÁManuel Álvarez-Lobos
Manuel Álvarez-Lobos
DPDaniel Paredes-Sabja
Daniel Paredes-Sabja
AGAna María Guzmán-Durán
Ana María Guzmán-Durán

22 October 2015 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
ÁPÁ. Plaza-Garrido
Á. Plaza-Garrido
Jonathan BarraJonathan Barra
Jonathan Barra
JMJuan Macias
Juan Macias
RCR. Carman
R. Carman
WFW. N. Fawley
W. N. Fawley
Daniel ParedesDaniel Paredes
Daniel Paredes
SUMMARY: In a 1-year survey at a university hospital we found that 20·6% (81/392) of patients with antibiotic associated diarrohea where positive for C. difficile. The most common PCR ribotypes were 012 (14·8%), 027 (12·3%), 046 (12·3%) and 014/020 (9·9). The incidence rate was 2·6 cases of C. difficile infection for every 1000 outpatients.